期刊文献+

幽门螺旋杆菌细胞毒素相关蛋白A真核表达载体的构建与表达 被引量:1

The Construction of the Helicobacter pylori Cytotoxin-Associated Protein A(CagA)Gene Eukaryotic Expression Vector and the Coding Protein Expression
下载PDF
导出
摘要 目的构建幽门螺旋杆菌(Helicobacter pylori,Hp)细胞毒素相关蛋白A(cytotoxin-associated protein,CagA)基因表达载体并表达其编码蛋白。方法从胃黏膜活检标本中分离Hp,提取核酸,采用RT-PCR技术扩增CagA基因,将其克隆至pEGFP真核表达载体中,构建Hp CagA基因真核表达载体并转染293-T细胞表达其编码蛋白。结果通过PCR、双酶切、测序鉴定证实CagA基因的真核表达载体构建成功,免疫印迹法证实CagA蛋白的表达。结论成功构建了Hp CagA基因真核表达载体并表达其编码蛋白,为后期功能研究提供了材料和基础。 Objective To construct the Helicobacter pylori cytotoxin associated protein A (CagA) gene eukaryotic expression vector and to express its coding protein. Method Helicobacter pylori from gastric mucosa biopsy specimens was isolated. Helicobacter pylori nucleic acid was extracted and the RT-PCR was used to amplify CagA gene, followed by cloning it into PEGFP eukaryotic expression vector, and transfected it onto 293-T ceils to express the coding protein. Results By the use of PCR,double enzyme digestion,and DNA sequencing, the CagA gene eukaryotic expression vector was constructed successfully and immunoblotting confirmed CagA protein expression. Conclusion We are successful in construction of Helicobacter pylori CagA gene eukaryotic expression vector and in the expression of the encoded protein,thus, providing the foundation for further studies.
出处 《成都医学院学报》 CAS 2013年第5期604-607,共4页 Journal of Chengdu Medical College
关键词 幽门螺旋杆菌 细胞毒素相关蛋白A基因 分子克隆 真核表达 Helicobacter pylori Cytotoxin-Associated Protein A Gene Molecular Clone Eukaryotic Expression
  • 相关文献

参考文献1

二级参考文献18

共引文献9

同被引文献27

  • 1姚方.埃索美拉唑在消化性溃疡病治疗中的地位[J].中华消化杂志,2006,26(5):355-357. 被引量:30
  • 2成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 3Sugimoto M,Yamaoka Y. Virulence factor genotypes of Heli- cobacter pylori affect cure rates of eradication therapy [J]. Arch Immunol Ther Exp(Warsz),2009,57( l ):45-56.
  • 4Uemura N,Okamoto S,Yamamoto S,et al. Helicobacter pylori infection and the development of gastric cancer [J]. N Engl J Med, 2001,345 ( 11 ) : 784-789.
  • 5Yan X,Zhou L, Song Z, et al. Sequential therapy for he- licobacter pylori eradication in adults compared with triple therapy in china :a multiplecenter, Prospective, randomized,controlled trial (abstract) [J]. Helicobacter, 2011,16(Suppl 1) :87.
  • 6Malfertheiner P, Bazzoli F, Delchier JC, et al. Helicobac- ter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline giv- en with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial [J]. Lancet, 2011,377 (9769) : 905-913.
  • 7Graham DY,Opekun AR,Klein PD. Clarithromycin for the eradication of Helieobacter pylori [J]. J Clin Gas- troenterol, 1993,16(4) : 292-294.
  • 8林楠,贾天柱小茴香化学成分及药理作用研究现状[C].中华中医药学会中药炮制分会2008年学术研讨会论文集,2008:154-157.
  • 9Malfertheiner P,Megraud F,O'Morain CA,et al. Man- agement of Helicobacter pylori infection--the Maastricht IV/Florence Consensus Report [J]. Gut,2012,61(5):646- 664.
  • 10Gisbert JP, Morena F. Systematic review and meta-analy- sis :levofloxacin-based rescue regimens after Helicobac- ter pylori treatment failure [J]. Aliment Pharmacol Ther, 2006,23 ( 1 ) : 35-44.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部